Nephrology

The research is noteworthy given a Supreme Court decision that could result in many dialysis patients switching from commercial insurance plans to Medicare.

Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people would consider living kidney donation, a new study found.

University of Pittsburgh Medical School researchers walk us through multiple approaches they’ve tried in the past, are currently using or plan to use in the future, as well as the significant challenges ahead.

Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost of $162,500 annually.

Previous research has found that immigrants have lower rates of heart disease, diabetes, dementia and other chronic health conditions compared with nonimmigrants. A new study adds kidney disease to the list.

This is the third approval for Fabhalta (iptacopan), which was discovered and developed by Novartis.

The Acute Dialysis and Pheresis Therapies (ADAPT) Program has grown from nine nurses to 12.

Patients with acute kidney injury requiring temporary hemodialysis often follow the protocol used for people on long-term dialysis, despite significant pathophysiological differences between the two.

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common complication of type 2 diabetes.

A Q&A with Jonathan Barratt, Ph.D., FRCP.

Vafseo, an oral therapy to treat patients with anemia due to chronic kidney, will be available in January 2025. About 40% of patients who could be treated with Vafseo have coverage through Medicare Advantage plans.

How successful accountable care organizations (ACOs) have been in bringing about value-based care hinges, of course, on how success is defined. CMS’ comprehensive end-stage renal disease (ESRD) care model is a good example.